drugset / Trial / NCT04194528
S1916 Digital Medicine Program for Pain Control in Cancer Patients
NaSingle-groupOpen-labelSupportive care
Summary
This is a feasibility study to assess the use of a Digital Medicine Program (consisting of an FDA-approved ingestible sensor co-encapsulated with oxycodone/acetaminophen (5 mg/325 mg), a small wearable patch, and a mobile application) in cancer patients with metastatic disease experiencing uncontrolled pain.
Timeline
- Start
- 2020-01-22
- Primary completion
- 2020-09-16
- Completion
- 2020-09-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Acetaminophen | Small molecule | 325 mg | — |
| Background | Oxycodone | Other / unclassified | 5 mg | — |